Simris Alg AB (publ) (SIMRIS-B.ST)
Simris Alg AB (publ) operates in the Biotechnology industry of the Healthcare sector, headquartered in Hammenhög, SN, SE. The stock last traded at $0.10, down 11.86% on the session, giving a market capitalisation of $140.4M. Its beta of 0.88 implies it has historically moved less than the broad market.
Operating both within Sweden and across global markets, Simris Alg AB (publ) specializes in the production and sale of nutritional supplements and food products derived from algae. Its product portfolio includes Simris Algae Omega-3, a unique plant-derived marine omega-3 supplement providing both EPA and DHA. Additionally, under its 'Simris Select' brand, the company provides a range of other algae-based items like premium chlorella, spirulina sprinkles, invigorating astaxanthin, and various algae teas such as 'flower power' and 'sun candy'. Established in 2010, the firm maintains its main office in Hammenhög, Sweden.
Simris Alg AB (publ) is most often compared with the following Healthcare names: